Where can I find CGNSF's financial statements?

Cognetivity Neurosciences Ltd. (CGNSF)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for CGNSF?

Cognetivity Neurosciences Ltd. (CGNSF) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does CGNSF update its statements?

Cognetivity Neurosciences Ltd. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

CGNSF

Cognetivity Neurosciences Ltd.

OTC·Medical, Healthcare Information Services · Healthcare

$0.00$0.00+0.00%

Market cap$8.96K·Market closed·Aug 25 8:00 PM UTC

CAD · values shown as reported

Line item	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023
Revenue	C$0.00	C$0.00	C$0.00	C$0.00	C$45.37K
Cost of revenue	C$3.94K+174.9%	C$9.29K+135.7%	C$11.45K+23.2%	C$24.53K+114.3%	C$2.18M+8,767.6%
Gross profit	−C$3.94K−174.9%	−C$9.29K−135.7%	−C$11.45K−23.2%	−C$24.53K−114.3%	−C$2.13M−8,582.7%
Research & development	C$732.37K+791.6%	C$492.18K−32.8%	C$71.00K−85.6%	C$491.23K+591.9%	C$601.15K+22.4%
General & administrative	C$2.46M+83.8%	C$1.61M−34.7%	C$2.09M+29.7%	C$11.52M+452.2%	C$5.04M−56.3%
Selling & marketing	C$855.93K+10,127.4%	C$402.02K−53.0%	C$230.80K−42.6%	C$945.81K+309.8%	C$575.70K−39.1%
SG&A (combined)	C$3.32M+146.0%	C$2.01M−39.5%	C$2.32M+15.3%	C$12.47M+438.0%	C$5.61M−55.0%
Other operating expenses	−C$432.00	C$103.08K+23,960.2%	−C$1.11M−1,177.6%	−C$4.00M−260.1%	−C$2.06M+48.6%
Total operating expenses	C$4.21M+182.0%	C$2.61M−38.1%	C$1.28M−51.0%	C$8.96M+601.3%	C$4.16M−53.6%
Operating income	−C$4.21M−183.3%	−C$2.60M+38.2%	−C$2.39M+8.1%	−C$13.04M−444.7%	−C$6.29M+51.7%
Interest income	C$21.40K+308.4%	—	—	—	—
Interest expense	—	C$55.98K	C$62.84K+12.3%	C$60.55K−3.6%	C$1.03M+1,596.9%
Other income / (expense), net	−C$105.77K−1,083.1%	—	C$467.46K	−C$148.04K−131.7%	−C$1.14M−672.2%
Income before tax	−C$4.19M−180.3%	−C$2.66M+36.5%	−C$1.93M+27.6%	−C$13.13M−581.7%	−C$7.43M+43.4%
Income tax expense	−C$21.83K−1,280.2%	−C$15.18K+30.5%	C$2.29K+115.1%	—	—
Net income	−C$4.19M−180.3%	−C$2.65M+36.9%	−C$1.93M+27.1%	−C$13.13M−580.8%	−C$7.43M+43.4%

EPS (basic)	−C$0.10−177.0%	−C$0.06+42.0%	−C$0.03+43.3%	−C$0.18−447.1%	−C$0.09+51.4%
EPS (diluted)	−C$0.10−177.0%	−C$0.06+42.0%	−C$0.03+43.3%	−C$0.18−447.1%	−C$0.09+51.4%
Weighted avg shares (basic)	40,411,435	45,598,134	58,675,419	73,057,477	85,049,178
Weighted avg shares (diluted)	40,411,435	45,598,134	58,675,419	73,057,477	85,049,178

Depreciation & amortization	C$3.94K+174.9%	C$9.29K+135.7%	C$11.45K+23.2%	C$24.53K+114.3%	C$24.63K+0.4%
EBITDA	−C$4.21M−183.3%	−C$2.60M+38.3%	−C$2.39M+7.8%	−C$13.01M−443.7%	−C$6.38M+51.0%

Frequently Asked Questions About CGNSF

Where can I find CGNSF's financial statements?: Cognetivity Neurosciences Ltd. (CGNSF)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for CGNSF?: Cognetivity Neurosciences Ltd. (CGNSF) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does CGNSF update its statements?: Cognetivity Neurosciences Ltd. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

Trend

Revenue

C$0.00

C$45.37K

Cost of revenue

C$3.94K+174.9%

C$9.29K+135.7%

C$11.45K+23.2%

C$24.53K+114.3%

C$2.18M+8,767.6%

Gross profit

−C$3.94K−174.9%

−C$9.29K−135.7%

−C$11.45K−23.2%

−C$24.53K−114.3%

−C$2.13M−8,582.7%

Research & development

C$732.37K+791.6%

C$492.18K−32.8%

C$71.00K−85.6%

C$491.23K+591.9%

C$601.15K+22.4%

General & administrative

C$2.46M+83.8%

C$1.61M−34.7%

C$2.09M+29.7%

C$11.52M+452.2%

C$5.04M−56.3%

Selling & marketing

C$855.93K+10,127.4%

C$402.02K−53.0%

C$230.80K−42.6%

C$945.81K+309.8%

C$575.70K−39.1%

SG&A (combined)

C$3.32M+146.0%

C$2.01M−39.5%

C$2.32M+15.3%

C$12.47M+438.0%

C$5.61M−55.0%

Other operating expenses

−C$432.00

C$103.08K+23,960.2%

−C$1.11M−1,177.6%

−C$4.00M−260.1%

−C$2.06M+48.6%

Total operating expenses

C$4.21M+182.0%

C$2.61M−38.1%

C$1.28M−51.0%

C$8.96M+601.3%

C$4.16M−53.6%

Operating income

−C$4.21M−183.3%

−C$2.60M+38.2%

−C$2.39M+8.1%

−C$13.04M−444.7%

−C$6.29M+51.7%

Interest income

C$21.40K+308.4%

—

Interest expense

—

C$55.98K

C$62.84K+12.3%

C$60.55K−3.6%

C$1.03M+1,596.9%

Other income / (expense), net

−C$105.77K−1,083.1%

—

C$467.46K

−C$148.04K−131.7%

−C$1.14M−672.2%

Income before tax

−C$4.19M−180.3%

−C$2.66M+36.5%

−C$1.93M+27.6%

−C$13.13M−581.7%

−C$7.43M+43.4%

Income tax expense

−C$21.83K−1,280.2%

−C$15.18K+30.5%

C$2.29K+115.1%

—

Net income

−C$4.19M−180.3%

−C$2.65M+36.9%

−C$1.93M+27.1%

−C$13.13M−580.8%

−C$7.43M+43.4%

EPS (basic)

−C$0.10−177.0%

−C$0.06+42.0%

−C$0.03+43.3%

−C$0.18−447.1%

−C$0.09+51.4%

EPS (diluted)

−C$0.10−177.0%

−C$0.06+42.0%

−C$0.03+43.3%

−C$0.18−447.1%

−C$0.09+51.4%

Weighted avg shares (basic)

40,411,435

45,598,134

58,675,419

73,057,477

85,049,178

Weighted avg shares (diluted)

40,411,435

45,598,134

58,675,419

73,057,477

85,049,178

Depreciation & amortization

C$3.94K+174.9%

C$9.29K+135.7%

C$11.45K+23.2%

C$24.53K+114.3%

C$24.63K+0.4%

EBITDA

−C$4.21M−183.3%

−C$2.60M+38.3%

−C$2.39M+7.8%

−C$13.01M−443.7%

−C$6.38M+51.0%